Loading clinical trials...

Lipoprotein and Apolipoproteins With Metabolic Liver Diseases | Clinical Trials | Clareo Health

UNKNOWNNCT03220971

Lipoprotein and Apolipoproteins With Metabolic Liver Diseases

Theranostic translation applications against viral, metabolic liver diseases and hepatic oncogenesis: lipoprotein and apolipoproteins at a crossroad

Lead sponsor: Chun-Hsiang Wang•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment440

Start dateSep 2017

Last updatedApr 19, 2018

Condition

Disorders of Lipoprotein Metabolism and Other Lipidaemias

Locations shown

Chun-Hsiang Wang

Tainan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions